Ownership history in DEARBORN PARTNERS LLC · 92 quarters on record
This page tracks every 13F SEC filing in which DEARBORN PARTNERS LLC reported a position in Abbott Labs Common Stock (ABT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 235,881 | -7,755 | -3.2% | 1.48% | $29.6M | $124.66 |
| 2025 Q3 | REDUCED | 243,636 | -1,090 | -0.4% | 1.53% | $32.6M | $132.67 |
| 2025 Q2 | ADDED | 244,726 | +1,993 | +0.8% | 1.58% | $33.3M | $134.12 |
| 2025 Q1 | REDUCED | 242,733 | -39,345 | -13.9% | 1.55% | $32.2M | $130.21 |
| 2024 Q4 | REDUCED | 282,078 | -3,619 | -1.3% | 1.34% | $31.9M | $110.45 |
| 2024 Q3 | REDUCED | 285,697 | -5,272 | -1.8% | 1.32% | $32.6M | $110.80 |
| 2024 Q2 | REDUCED | 290,969 | -1,317 | -0.5% | 1.31% | $30.2M | $100.45 |
| 2024 Q1 | REDUCED | 292,286 | -70,488 | -19.4% | 1.43% | $33.2M | $109.34 |
| 2023 Q4 | REDUCED | 362,774 | -5,475 | -1.5% | 1.45% | $39.9M | $105.38 |
| 2023 Q3 | REDUCED | 368,249 | -1,466 | -0.4% | 1.40% | $35.7M | $92.21 |
As of 2025 Q4 — sorted by position size